Followers | 256 |
Posts | 18838 |
Boards Moderated | 3 |
Alias Born | 12/02/2014 |
Monday, August 29, 2022 11:01:20 AM
TUTUM HEALTH CLINICAL TRIAL AND SUPPLY CHAIN SUCCESS
We are delighted to share some exciting news following from a successful clinical trial and study that took place in 2021 around the efficacy of the Pathisol Annihilyzer and the methodology of application and training.
Dear Art Abraham,
We are delighted to share some exciting news following from a successful clinical
trial and study that took place in 2021 around the efficacy of the Pathisol Annihilyzer
and the methodology of application and training. The trial was centred around using
Hypochlorous Acid, produced via our on-site generator and applied using
electrostatic equipment to disinfect several NHS Hospital wards which
produced positive results. Due to ward occupancy of visitors due to COVID-19 in
2021 a further smaller study is also planned in March 2022 across a few hospital
wards to back-up initial study results.
We have been also awarded onto a second National Healthcare framework. The
latest being the NHS supply chain (the biggest NHS provider of equipment) and is
expected to go live in March 2022. This means our advanced technology is
accessible throughout the NHS and to healthcare providers who wish to use the ecofriendly, highly effective cleaning products, all while reducing their carbon footprint.
The white paper that denotes the success of the initial and second trial is planned to be published in the first quarter of this year (2022). This is an incredible opportunity, and we are thrilled with the progress made so far that paves the way for a brighter future for cleanliness and hygiene standards.
Kevin Gray, Tutum Health CEO
https://tutumhealth.co.uk/news/
Recent PCTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 02:05:09 PM
- Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/18/2023 07:06:52 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/13/2023 04:32:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM